Ligand Pharmaceuticals Incorporated (LGND)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 87.00 |
| Open | 87.01 |
| Bid | 86.70 x 100 |
| Ask | 87.62 x 100 |
| Day's range | 86.93 - 88.21 |
| 52-week range | 49.24 - 94.57 |
| Volume | |
| Avg. volume | 189,456 |
| Market cap | 1.568B |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | 16.25 |
| EPS (TTM) | 5.37 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 July 2010 |
| 1y target est | 116.80 |
ZacksAstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
ZacksDyne (DYN) Soars 28% on New Data From Muscle Disease Studies
Dyne (DYN) gains 28% after reporting positive new data from two separate ongoing mid to late-stage studies evaluating DYNE-101 and DYNE-251 for different muscle disease indications.
ZacksPTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
PTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP opinion of January 2024 on the annual renewal of the conditional approval of Translarna.
© 2024 Yahoo. All rights reserved.